We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
182 hedge funds and large institutions have $3.03B invested in Acadia Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 53 increasing their positions, 68 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
231% more call options, than puts
Call options by funds: $105M | Put options by funds: $31.7M
192% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 12
30% more capital invested
Capital invested by funds: $2.33B → $3.03B (+$696M)
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
12% more funds holding
Funds holding: 162 → 182 (+20)
22% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 68
Holders
182
Holders Change
+20
Holders Change %
+12.35%
% of All Funds
4.85%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.21%
New
35
Increased
53
Reduced
68
Closed
12
Calls
$105M
Puts
$31.7M
Net Calls
+$73.1M
Net Calls Change
-$148M
Top Buyers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$24.5M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$18.4M |
| 3 |
JP Morgan Chase
New York
|
+$15.2M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$15M |
| 5 |
CCI
Columbus Circle Investors
|
+$12.2M |
Top Sellers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$38.8M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$13.9M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.3M |
| 4 |
Bank of New York Mellon
New York
|
-$8.23M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$7.58M |
